Molecular mechanisms of cisplatin-induced nephrotoxicity: a balance on the knife edge between renoprotection and tumor toxicity

Cullen KJ(2007)Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancer J Bioenerg Biomembr 39 43-50

Yang Z(2010)Induction chemotherapy for head and neck cancer: recent data Oncologist. 15 3-7

Schumaker L(2008)Esophageal Cancer chemotherapy: recent advances Gastrointest Cancer Res 2 85-92

Guo Z(2011)Chemotherapy in advanced bladder cancer: current status and future J Hematol Oncol 4 35-1577

Vokes EE(2003)Long-term complications of chemotherapy for germ cell tumours Drugs. 63 1565-1955

Ilson DH(1996)Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer N Engl J Med 335 1950-1033

Ismaili N(2010)Endometrial carcinoma: a review of chemotherapy, drug resistance, and the search for new agents Oncologist. 15 1026-1153

Amzerin M(1999)Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer N Engl J Med 340 1144-S121

Flechon A(2012)Cisplatin in breast cancer treatment in BRCA1 carriers Hered Cancer Clin Pract 10 A17-S396

Chaudhary UB(2007)Phase II study of low-dose paclitaxel and cisplatin as a second-line therapy after 5-fluorouracil/platinum chemotherapy in gastric cancer J Korean Med Sci. 22 S115-S578

Cullen KJ(2007)Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancer J Bioenerg Biomembr 39 43-50

Yang Z(2010)Induction chemotherapy for head and neck cancer: recent data Oncologist. 15 3-7

Schumaker L(2008)Esophageal Cancer chemotherapy: recent advances Gastrointest Cancer Res 2 85-92

Guo Z(2011)Chemotherapy in advanced bladder cancer: current status and future J Hematol Oncol 4 35-1577

Vokes EE(2003)Long-term complications of chemotherapy for germ cell tumours Drugs. 63 1565-1955

Ilson DH(1996)Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer N Engl J Med 335 1950-1033

Ismaili N(2010)Endometrial carcinoma: a review of chemotherapy, drug resistance, and the search for new agents Oncologist. 15 1026-1153

Amzerin M(1999)Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer N Engl J Med 340 1144-S121

Flechon A(2012)Cisplatin in breast cancer treatment in BRCA1 carriers Hered Cancer Clin Pract 10 A17-S396

Chaudhary UB(2007)Phase II study of low-dose paclitaxel and cisplatin as a second-line therapy after 5-fluorouracil/platinum chemotherapy in gastric cancer J Korean Med Sci. 22 S115-S578